Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Burst CME™ Part V: Complement Inhibitors in IgAN
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part IV: Anti-CD38 Therapies in IgAN
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part III: BAFF and APRIL Directed Therapies in IgAN
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part II: Endothelin A Receptor Antagonists in IgAN
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™ Part I: What’s New in IgAN?
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Burst CME™: Elevating Care in the Management of IgA Nephropathy (IgAN) Nursing Track
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
Project ECHO®: CAR T in Practice: Identifying Eligible Patients Across Hematologic Malignancies
Jesús G. Berdeja, MD; Michael Byrne, DO, FACP
ADCs and Bispecific Antibodies Across Solid Tumors: Integrating New Targets, New Data, and New Decisions
William J. Gradishar, MD, FASCO, FACP; Rebecca Arend, MD, MSPH; Aaron Lisberg, MD; Ulka Vaishampayan...
Cases and Conversations™: Uniting Heart and Kidney Care: Optimizing Outcomes in Cardio-Kidney-Metabolic Disorders
Katherine E. Di Palo, PharmD, MBA, MS; Nancy M. Albert, PhD, APRN-CCNS, CHFN, CCRN, NE-BC, FCCM, FAH...
Live Tumor Board: Exploring Novel Targets and Breakthrough Treatment Strategies in Extrapulmonary Neuroendocrine Carcinomas
Aman Chauhan, MD, MBBS; Jonathan Strosberg, MD; Sylvia L. Asa, MD, PhD
Medical Crossfire®: Closing Clinical Practice Gaps in Hepatobiliary Cancer With Emerging Immunotherapies and Delivery Innovations
Ghassan Abou-Alfa, MD, MBA; Riad Salem, MD, MBA; Rachna Shroff, MD, MS, FASCO; Arndt Vogel, MD, PhD
Cases and Conversations: Optimizing Oral SERD-Based Therapy After CDK4/6 Inhibition in HR+/HER2– MBC
Virginia Kaklamani, MD, DSc; Antonio Giordano, MD, PhD; Nadia Harbeck, MD, PhD; Sarah Sammons, MD
Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia
Gabriela Hobbs, MD; Rami Komrokji, MD; Douglas A. Tremblay, MD
Tumor Board: Evolving Immunotherapy Strategies for Stage I-III NSCLC
Tina Cascone, MD, PhD; Puneeth Iyengar, MD, PhD; Paula A. Ugalde Figueroa, MD
Hot Seat: Which Agent, and When? Integrating Next-Generation Endocrine Strategies Into HR+/HER2– Breast Cancer Management
Ruta D. Rao, MD; Kamel Abou Hussein, MD; Jame Abraham MD, FACP; Paolo Tarantino, MD, PhD
Cases and Conversations: Applying the Evidence – Real-World Strategies to Optimize Care for Patients With Myelofibrosis
Ruben A. Mesa, MD, FACP; Andrew Kuykendall, MD; Sangeetha Venugopal, MD, MS
Medical Crossfire®: Precision Oncology in NSCLC – Translating HER2 and TROP2 Innovation into Practice-Changing Care
Benjamin P. Levy, MD; Sarah Goldberg, MD, MPH; Jacob Sands, MD; Helena Yu, MD
BURST CME™ Activity 1: Foundations of Endocrine Resistance and Oral SERDs in HR+/HER2– Metastatic Breast Cancer
Adam Brufsky, MD, PhD; Manali Bhave, MD
BURST CME™ Activity 2: Oral SERD Monotherapy: Understanding the Evidence Base
Adam Brufsky, MD, PhD; Manali Bhave, MD
Tumor Board: Optimizing NSCLC Care—Leveraging the Latest Evidence on Targeted Therapy and Immuno-Oncology
Enriqueta Felip, MD, PhD; Justin Gainor, MD; Julia Rotow, MD; Urs Weber, MD
Show Me the Data™: Redefining Treatment Paradigms in Triple-Negative Breast Cancer Across the Disease Continuum
Hope S. Rugo, MD, FASCO; Neil M. Iyengar, MD; Heather McArthur, MD, MPH; Jason Aboudi Mouabbi, MD
From Dropout to Long-Term Wear—A Case-Based Approach to Personalized Contact Lens Care
Adam Ramsey, OD; Jessilin Quint, OD, MBA, MS, FAAO
Expanding the Fit—Mastering Toric and Multifocal Success in Complex Patients
Adam Ramsey, OD; Jessilin Quint, OD, MBA, MS, FAAO
Advances in™ Generalized Myasthenia Gravis: Continuing the Quest for Novel Therapies
James F. Howard Jr, MD, FAAN; Tuan Vu, MD
Modality Matters—Optimizing Contact Lens Selection for Real-World Wear
Adam Ramsey, OD; Jessilin Quint, OD, MBA, MS, FAAO
Beyond the Itch—Decoding the Immunopathology of Allergic Conjunctivitis
Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO
Mechanism Matters—How OTC Therapies Interrupt the Allergic Cascade
Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO
From Chair to Care Plan—Applying Evidence to Patient-Centered Management
Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO
Timing Is Everything—Onset, Duration, and Dosing in Real-World Care
Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO
Practical Strategies for Monitoring and Managing Toxicities With Novel Therapies for HER2-Positive Gastroesophageal Adenocarcinoma
Samuel J. Klempner, MD, FASCO; Christian Baglini, MS, AGNP-BC; Jonathan N. Glickman, MD, PhD
Oncology Town Hall: Updates From Chicago: Oral SERDs in HR+/HER2− Metastatic Breast Cancer–What the Latest Data Really Tell Us
Virginia Kaklamani, MD, DSc; Kamel Abou Hussein, MD; Javier Cortés, MD, PhD; Seth A. Wander, MD, PhD
Selecting an Optimal Therapeutic Strategy for the Management of Atopic Dermatitis in Young Children
Elaine Siegfried, MD; Lawrence F. Eichenfield, MD
Obesity: New and Emerging Strategies to Optimally Manage a Chronic Disease
Scott Kahan, MD, MPH; Robert F. Kushner, MD, MS, DABOM; Christopher D. Still, DO, FACP, FTOS
Oncology Town Hall: Updates From Berlin: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us
Hope S. Rugo, MD, FASCO; Fabrice André, MD, PhD; Heather McArthur, MD, MPH; Nadia Harbeck, MD
Medical Crossfire®: Turning Therapeutic Innovation Into Practice—Personalizing Care in Multiple Myeloma
Mohamad Mohty, MD, PhD; Shaji K. Kumar, MD; Suzanne Lentzsch, MD, PhD; Philippe Moreau, MD
The New DED Toolkit: Innovative Therapies Reshaping Dry Eye Management
Laura M. Periman, MD; Kristin Barnes, OD; Selina McGee, OD, FAAO, Dipl ABO; Neda Shamie, MD
Cases and Conversations®: Advancing Diagnosis and Long-Term Management of CIDP
Karissa Gable, MD; Jeffrey Allen, MD; Suraj Muley, MD, FAAN
Live Tumor Board: Translating Biomarker Insights and Therapeutic Advances Into Endometrial Cancer Practice
Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA; Casey Cosgrove, MD; Ebony R. Hoskins, MD, FA...
Primary Care Playbook: Advancing COVID-19 Prophylaxis in Community Practice
Chuck Vega, MD; Stefan Gravenstein MD, MPH
Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy
Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Ashley S. Margol, MD, MS
Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer
Rachel N. Grisham, MD; David M. Gershenson, MD; Ursula Matulonis, MD; David M. O’Malley, MD
Community Practice Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma
Lori A. Leslie, MD; Krish Patel, MD
PER® Postgame™: Addressing the Unmet Medical Needs of Patients with Psoriasis—Summarizing the Latest Advancements in Oral Therapy
Jason E. Hawkes, MD, MS; Christopher G. Bunick, MD, PhD
Show Me the Data®: Evolving Standards and New Frontiers in Ovarian Cancer
Ursula A. Matulonis, MD; Bradley J. Monk, MD, FACS, FACOG; Ritu Salani, MD, MBA; Oladapo Yeku, MD, P...
Advancing Presbyopia Care: Patient-Centered Strategies for Pharmacologic Management
Brian Szabo, DO; Nick Bruns, OD, FAAO
Searching for Silence: Corneal Sensitivity Testing in NK
Francis Mah, MD; Amy Nau, OD , FAAO, Dipl. CCLRT
From Data to Decisions: Applying the Latest Evidence for New Targeted Therapies in HER2-Positive Gastroesophageal Adenocarcinoma
Pashtoon Kasi, MD, MS; Elizabeth Conner, MD; Simona De Michele, MD












































